1-5 of 5
Zhongjun Xia, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Expression of Paks and Its Clinical Significance in T-Cell Lymphoblastic Lymphoma

Qingqing Cai, PhD, Ning Su, MM, Yu Fang, BMBS, Xu Chen, MDPhD, Xiaopeng Tian, MDPhD, Shuyun Ma, MM, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Tongyu Lin, MD PhD, Huiqiang Huang, MDPhD, Zhiming Li, MD PhD, Xueyi Pan, MDPhD, Yi Xia, MD PhD, Panpan Liu, MD PhD, Xuanye Zhang, MDPhD, Hang Yang, MD PhD, Stephen Yang Liang, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–16.
https://doi.org/10.1182/blood-2020-136975
Published: 2020
Journal Articles

Development and Validation of a Risk Assessment Model for Early Infection during the First 3 Months in Patients with Newly Diagnosed Multiple Myeloma

Yufeng Shang, Weida Wang, MD PhD, Minghui Liu, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Fuling Zhou, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-141735
Published: 2020
Journal Articles

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Qingqing Cai, PhD, Huiqiang Huang, MDPhD, Yuchen Zhang, Panpan Liu, MD PhD, Hongmei Jing, MD PhD, Ping Yang, MD PhD, Tongyu Lin, MD PhD, Zhongjun Xia, MDPhD, Zhiming Li, MD PhD, Wenyu Li, PhD, Liye Zhong, MD PhD, Xu Ye, MD PhD, Xueli Jin, MD PhD, Liling Zhang, MD PhD, Huilai Zhang, MD PhD, Xiuhua Sun, MD, Yuyang Tian, MM, Shuyun Ma, MM, Ning Su, MM, Jun Cai, BMBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-136842
Published: 2020
Journal Articles

A Phase 1 Dose-Escalation Study of LH031, a Kinesin Spindle Protein Inhibitor, in Patients with Refractory/Resistance Multiple Myeloma

Zhongjun Xia, MDPhD, Su Li, Xiaoqin Chen, MDPhD, Weida Wang, MD PhD, Yan Song
Journal: Blood
Blood (2020) 136 (Supplement 1): 37.
https://doi.org/10.1182/blood-2020-137346
Published: 2020
Journal Articles

Updated Results from the Phase II Study of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

Wei Xu, MD PhD, Yongping Song, MD, Tingyu Wang, Shenmiao Yang, Lihong Liu, MD, Yu Hu, MD, Wei Zhang, Jianfeng Zhou, MD PhD, Sujun Gao, Kaiyang Ding, Huilai Zhang, MD PhD, Zunmin Zhu, MD, Shun-Qing Wang, Bing Xu, MD PhD, Jianda Hu, Ting Liu, MD PhD, Chunyan Ji, MD, Zhongjun Xia, MDPhD, Yan Li, PhDMD, Xin Wang, MDPhD, Huaqiang Zhu, MD, Renbin Zhao, PhD, Bin Zhang, PhD, Zhixin Xu, MD PhD, Jianyong Li, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-134531
Published: 2020